Magnesium (Threonate/Glycinate) for Sleep & Cognitive Support — Brain
Essential mineral in bioavailable forms with moderate evidence for sleep quality improvement, cognitive function, and neuromuscular support.
Overview
Magnesium is an essential mineral cofactor for over 600 enzymatic reactions in the human body, including ATP synthesis, DNA replication, protein synthesis, and neuromuscular function. Despite its critical importance, subclinical magnesium deficiency affects an estimated 50-80% of the Western population due to declining soil mineral content, food processing, and inadequate dietary intake. Magnesium supplementation for sleep and cognitive function has gained particular interest, with specific forms offering advantages for CNS bioavailability. Magnesium L-threonate (Magtein) is the only magnesium compound shown to significantly increase cerebrospinal fluid magnesium levels by crossing the blood-brain barrier. In a double-blind RCT in older adults with cognitive complaints, magnesium threonate improved executive function and working memory (cognitive age reversal of approximately 9 years). Magnesium glycinate (bisglycinate chelate) is highly bioavailable and well tolerated, with the glycine carrier providing additional calming effects through glycine receptor activation. For sleep, a meta-analysis of RCTs found that magnesium supplementation reduced sleep onset latency, improved sleep quality, and increased total sleep time, with the strongest effects in elderly populations with low baseline magnesium. Magnesium activates the parasympathetic nervous system, regulates GABA-B receptor function, and modulates NMDA receptor activity, all contributing to its calming and sleep-promoting effects.
Indications
- Moderate evidence: Sleep quality improvement (meta-analysis of RCTs)
- Moderate evidence: Cognitive function (magnesium threonate for executive function)
- Strong evidence: Magnesium deficiency repletion (hypomagnesemia)
- Moderate evidence: Muscle cramp prevention
- Moderate evidence: Migraine prophylaxis (AAN Level B recommendation)
- Moderate evidence: Anxiety reduction (GAD, stress-related)
Mechanism of Action
Magnesium potentiates GABA-B receptor function and increases GABA availability, enhancing the primary inhibitory neurotransmitter system for calming and sleep
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Magnesium L-threonate (Magtein) | 2000 mg (144 mg elemental Mg) | Divided: 1 capsule morning, 2 capsules evening | Only form shown to cross BBB; cognitive + sleep |
| Magnesium bisglycinate | 200-400 mg (elemental Mg) | Once daily at bedtime | High bioavailability, well tolerated; sleep and muscle relaxation |
| Magnesium citrate | 200-400 mg (elemental Mg) | Once daily | Good bioavailability; may cause loose stools at higher doses |
| Magnesium chloride (spray/bath) | Variable | As desired | Transdermal absorption debated; anecdotal benefit for muscle relaxation |
Evidence Grade
GRADE B
Safety & Contraindications
- GI side effects (diarrhea, loose stools) most common — less with threonate and glycinate forms
- Magnesium oxide and citrate are more likely to cause GI symptoms
- Caution in renal impairment — magnesium is renally excreted; risk of hypermagnesemia
- May reduce absorption of fluoroquinolones, tetracyclines, and bisphosphonates — separate by 2+ hours
- High doses (>350 mg elemental Mg above dietary) may cause hypotension, especially with antihypertensives
- Threonate may cause headache or drowsiness during initial days